Share-based Payment Arrangement, Expense of NEVRO CORP from 31 Dec 2012 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
NEVRO CORP quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2012 to 31 Dec 2024.
  • NEVRO CORP Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2024 was $12,506,000, a 8.2% decline year-over-year.
  • NEVRO CORP Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2024 was $51,188,000, a 10% decline year-over-year.
  • NEVRO CORP annual Share-based Payment Arrangement, Expense for 2024 was $51,188,000, a 10% decline from 2023.
  • NEVRO CORP annual Share-based Payment Arrangement, Expense for 2023 was $56,865,000, a 0.12% increase from 2022.
  • NEVRO CORP annual Share-based Payment Arrangement, Expense for 2022 was $56,798,000, a 28% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

NEVRO CORP Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $51,188,000 $12,506,000 -$1,110,000 -8.2% 01 Oct 2024 31 Dec 2024 10-K 04 Mar 2025 2024 FY
Q3 2024 $52,298,000 $11,423,000 -$2,100,000 -16% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $54,398,000 $14,421,000 -$1,745,000 -11% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $56,143,000 $12,838,000 -$722,000 -5.3% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $56,865,000 $13,616,000 -$1,191,000 -8% 01 Oct 2023 31 Dec 2023 10-K 04 Mar 2025 2024 FY
Q3 2023 $58,056,000 $13,523,000 -$1,683,000 -11% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $59,739,000 $16,166,000 +$2,789,000 +21% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024 2024 Q2
Q1 2023 $56,950,000 $13,560,000 +$152,000 +1.1% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q4 2022 $56,798,000 $14,807,000 01 Oct 2022 31 Dec 2022 10-K 04 Mar 2025 2024 FY
Q3 2022 $15,206,000 01 Jul 2022 30 Sep 2022 10-Q 01 Nov 2023 2023 Q3
Q2 2022 $13,377,000 01 Apr 2022 30 Jun 2022 10-Q 01 Aug 2023 2023 Q2
Q1 2022 $13,408,000 01 Jan 2022 31 Mar 2022 10-Q 26 Apr 2023 2023 Q1
Q3 2014 $436,000 +$13,000 +3.1% 01 Jul 2014 30 Sep 2014 10-Q 02 Dec 2014 2014 Q3
Q3 2013 $423,000 01 Jul 2013 30 Sep 2013 10-Q 02 Dec 2014 2014 Q3

NEVRO CORP Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $51,188,000 -$5,677,000 -10% 01 Jan 2024 31 Dec 2024 10-K 04 Mar 2025 2024 FY
2023 $56,865,000 +$67,000 +0.12% 01 Jan 2023 31 Dec 2023 10-K 04 Mar 2025 2024 FY
2022 $56,798,000 +$12,433,000 +28% 01 Jan 2022 31 Dec 2022 10-K 04 Mar 2025 2024 FY
2021 $44,365,000 +$1,710,000 +4% 01 Jan 2021 31 Dec 2021 10-K 23 Feb 2024 2023 FY
2020 $42,655,000 +$958,000 +2.3% 01 Jan 2020 31 Dec 2020 10-K 21 Feb 2023 2022 FY
2019 $41,697,000 +$5,060,000 +14% 01 Jan 2019 31 Dec 2019 10-K 23 Feb 2022 2021 FY
2018 $36,637,000 +$10,494,000 +40% 01 Jan 2018 31 Dec 2018 10-K 24 Feb 2021 2020 FY
2017 $26,143,000 +$10,383,000 +66% 01 Jan 2017 31 Dec 2017 10-K 25 Feb 2020 2019 FY
2016 $15,760,000 +$8,435,000 +115% 01 Jan 2016 31 Dec 2016 10-K 21 Feb 2019 2018 FY
2015 $7,325,000 +$5,327,000 +267% 01 Jan 2015 31 Dec 2015 10-K 22 Feb 2018 2017 FY
2014 $1,998,000 +$398,000 +25% 01 Jan 2014 31 Dec 2014 10-K 23 Feb 2017 2016 FY
2013 $1,600,000 +$475,000 +42% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
2012 $1,125,000 01 Jan 2012 31 Dec 2012 10-K 18 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.